Bile Duct Cancers

Posted 3 weeks ago by Wales Gene Park

This is a multicenter, prospective, randomized, controlled phase III trial designed to assess the clinical performance of gemcitabine with cisplatin and observation vs. standard of care (observation alone in stage 1 and capecitabine and observation in stage 2) in patients after curative intent resection of BTC including an embedded sub-study for R1 resected patients receiving additional chemoradiation.

 Bile Duct Cancers /  Velindre Cancer Centre

Posted 3 weeks ago by Wales Gene Park

The purpose of this study is to evaluate the efficacy and safety of pemigatinib versus gemcitabine plus cisplatin chemotherapy in first-line treatment of participants with unresectable or metastatic cholangiocarcinoma with FGFR2 rearrangement.

 Bile Duct Cancers /  Velindre Cancer Centre


No post found